Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion type Assertion NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_head.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion wasGeneratedBy ECO_0000203 NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_provenance.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion wasDerivedFrom befree-20150227 NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_provenance.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion SIO_000772 15328326 NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_provenance.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion evidence source_evidence_literature NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_provenance.
- NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_assertion description "[In contrast with SDHD mutation carriers (PGL-1) who have more frequent multifocal paragangliomas, SDHB mutation carriers (PGL-4) are more likely to develop malignant disease and possibly extraparaganglial neoplasias, including renal cell and thyroid carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688859.RAvtc_n4t7ohptTnsRba9eWDb6hXpVP15WILrxk0kR9t8130_provenance.